Journal profile · Ophthalmology
Clinical and Experimental Ophthalmology
ISSN 1442-6404 · eISSN 1442-9071 · Wiley-Blackwell Publishing Ltd · AUSTRALIA · Monthly · Founded 2000
Clinical and Experimental Ophthalmology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 5.1; hybrid open access; APC about USD 4,150; median 80 days to acceptance (80 articles, last 24 months); community-reported acceptance: easy; 187 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Clinical and Experimental Ophthalmology is published by Wiley-Blackwell Publishing Ltd and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Glaucoma and retinal disorders, Retinal Diseases and Treatments and Intraocular Surgery and Lenses, together about 33.4% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Clinical & Experimental Ophthalmology (CEO) is the official journal of The Royal Australian and New Zealand College of Ophthalmologists.The journal publishes peer-reviewed original research and reviews dealing with all aspects of clinical practice and research, which are international in scope and application.The acceptance criteria for all papers are the quality, originality and significance of the research. Final acceptance or rejection rests with the Editorial Board.Formerly known as the Australian and New Zealand Journal of Ophthalmology.
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Editorial board by country: none in mainland China; most named Hong Kong, China 2, Singapore 1, New Zealand 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Glaucoma and retinal disordersMedicine14%
- Retinal Diseases and TreatmentsMedicine10.9%
- Intraocular Surgery and LensesMedicine8.5%
- Corneal surgery and disordersMedicine7.3%
- Ophthalmology and Visual Impairment StudiesMedicine7.1%
- Retinal and Macular SurgeryMedicine5.3%
- Ocular Diseases and Behçet’s SyndromeMedicine5.2%
- Ocular Infections and TreatmentsMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Ophthalmology | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCAB AbstractsCurrent ContentsPublisher website
Other: EBSCO, ProQuest
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 5.1LetPub ·
- Impact factor (publisher)
- 5.1Publisher website ·
- Impact factor (publisher) 2025
- 5.1Publisher website ·
- CiteScore 2026-06
- 9.3LetPub ·
- CiteScore (publisher)
- 9.3Publisher website ·
- CiteScore (publisher) 2025
- 9.3Publisher website ·
- SJR 2026-06
- 1.94LetPub ·
- SNIP 2026-06
- 2.48LetPub ·
- h-index
- 67LetPub ·
- h-index
- 107OpenAlex ·
- i10-index
- 2,170OpenAlex ·
- 2-year mean citedness
- 2.44OpenAlex ·
- Self-citation rate
- 9.8%LetPub ·
- Share of gold OA articles
- 53.85%LetPub ·
Volume
- Articles per year
- 83LetPub ·
- Articles per year (publisher)
- 2Publisher website ·
- Articles per year (publisher) 2025
- 155Publisher website ·
- Downloads per year (publisher) 2025
- 413,675Publisher website ·
Articles by year OpenAlex count · 5,562 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 136 | 69 | 50 |
| 2025 | 187 | 114 | 361 |
| 2024 | 146 | 103 | 735 |
| 2023 | 150 | 91 | 1,172 |
| 2022 | 164 | 52 | 2,549 |
| 2021 | 162 | 38 | 2,158 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
80 daysMedian, submission to acceptance · P25–P75 32 days – 148 days
- Acceptance to online
- median 21 days (87 articles)
- Submission to online
- median 95 days
- Sample
- 80 articles with submission and acceptance dates (344 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- 4–8 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 9%Publisher website ·
- Acceptance rate (publisher) 2025
- 9%Publisher website ·
- Submission to first decision
- 8 daysPublisher website ·
- Submission to first decision 2025
- 8 daysPublisher website ·
- Submission to acceptance 2025
- 68 daysPublisher website ·
- Acceptance to publication 2025
- 19 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,150 / EUR 3,470 / GBP 2,780 | — | — | |
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted10, with length limits
- correspondenceEditorial (by invitation) 1,000–1,200 words Maximum 15 references Original Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Result…Length not stated
- editorialEditorial (by invitation) 1,000–1,200 words Maximum 15 references Original Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Result…main text ≤ 1,200 words
- editorial (by invitation)Editorial (by invitation) 1,000–1,200 words Maximum 15 referencesLength not stated
- letter to the editorEditorial (by invitation) 1,000–1,200 words Maximum 15 references Original Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Result…main text ≤ 800 words · references ≤ 5
- letter to the editor – clinical or laboratory scienceLetter to the Editor – Clinical or Laboratory Science Maximum 800 words (no subheadings) Maximum 5 references Maximum 2 tables/figures Maximum 4 authors (other …Length not stated
- letter to the editor – correspondenceLetter to the Editor – Correspondence Maximum 600 words (no subheadings) Maximum 5 references Maximum 4 authors (other contributors to be included in acknowledg…Length not stated
- original articleEditorial (by invitation) 1,000–1,200 words Maximum 15 references Original Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Result…main text ≤ 4,000 words · references ≤ 50
- original article – clinical scienceOriginal Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Results, 4. Discussion Acknowledgements Maximum 4,000 words Maximum 50 r…Length not stated
- original article – laboratory scienceOriginal Article – Laboratory Science Structured abstract 1. Introduction, 2. Methods, 3. Results, 4. Discussion Acknowledgements Maximum 4,000 words Maximum 50…Length not stated
- reviewEditorial (by invitation) 1,000–1,200 words Maximum 15 references Original Article – Clinical Science Structured abstract 1. Introduction, 2. Methods, 3. Result…main text ≤ 6,000 words · references ≤ 100
Policy excerpts from the journal's websiteAI use, Authorship, Data availability, License & copyright, Open access, Peer review, Preprints, Trial registration / reporting guidelines
- AI use
AI: AI applications will not be recognised as manuscript authors; use must be transparently declared Model summary
Due to the inability of AI applications to fully meet the criteria for authorship outlined by the ICMJE, the journal will not recognise such applications as manuscript authors.
Source ↗Publisher website ·- Authorship Authorship
Authorship: adheres to ICMJE definition of authorship Model summary
The journal adheres to the definition of authorship set up by the International Committee of Medical Journal Editors (ICMJE). The ICMJE recommends that authorship be based on the following 4 criteria:
Source ↗Publisher website ·- Data availability Data Sharing and Data Availability
This journal expects data sharing. Review Wiley’s Data Sharing policy where you will be able to see and select the data availability statement that is right for your submission.
Source ↗Publisher website ·- License & copyright Reproduction of Copyright Material
If excerpts from copyrighted works owned by third parties are included, credit must be shown in the contribution. It is your responsibility to also obtain written permission for reproduction from the copyright owners. For more information visit Wiley’s Copyright Terms & Conditions FAQ.
Source ↗Publisher website ·- Open access Open Access
Submission fees: none Model summary
This journal is a subscription journal that offers an Open Access option. You will have the option to make your article open access after acceptance, which will be subject to an article processing charge (APC) unless a waiver applies. Read more about APCs here.
Source ↗Publisher website ·- Peer review 1. Submission and Peer Review Process
Peer review: single anonymised model Model summary
New submissions should be made via the Research Exchange submission portal https://authors.wiley.com/journal/CEO. You may check the status of your submission at any time by logging on to authors.wiley.com and clicking the “My Submissions” button. If you require assistance with your submission, please email the Managing Editor at ceojournal@ranzco.edu. For technical help with the submission system,…
Source ↗Publisher website ·- Preprints
Preprint policy: accepts articles previously published on preprint servers Model summary
This journal accepts articles previously published on preprint servers.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
Clinical & Experimental Ophthalmology supports the registration of trials as an important initiative to improve the reporting of clinical studies.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Wiley-Blackwell Publishing Ltd
- Country or region
- AUSTRALIA
- Language
- English
- Frequency
- Monthly
- Founded
- 2000
- ISSN
- 1442-6404
- Electronic ISSN
- 1442-9071
- Society / sponsor
- Royal Australian and New Zealand College of Ophthalmologists
- Latest issue on the website
- Volume 54, Issue 6 (August 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Clinical and Experimental Ophthalmology
What CAS zone is Clinical and Experimental Ophthalmology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Clinical and Experimental Ophthalmology is in Zone 2 of Medicine, and in Zone 2 of the minor category Ophthalmology. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Clinical and Experimental Ophthalmology?
The latest impact factor listed by LetPub is 5.1; CiteScore 9.3, h-index 107.
How long does peer review take at Clinical and Experimental Ophthalmology?
Based on the dates recorded on 80 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 80 days (interquartile range 32–148 days); authors report an average review time of 4–8 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 9% (2025). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Clinical and Experimental Ophthalmology based?
Of the 4 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Hong Kong, China (2), Singapore (1) and New Zealand (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Clinical and Experimental Ophthalmology?
According to LetPub and DOAJ records, Clinical and Experimental Ophthalmology is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is Clinical and Experimental Ophthalmology open access, and what is the APC?
Clinical and Experimental Ophthalmology is a hybrid journal. For open-access publication: APC about USD 4,150.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .